Concepedia

Author

Steve Sugarman

The University of Texas MD Anderson Cancer Center

Also Known As

Steve Sugarman

3

Publications

238

Citations

3

H-Index

13

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center
SS

About

Steve Sugarman is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer therapeutics, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

44

2

Pharmacology

2

2

44

3

Immunology

1

1

30

4

Pathology

1

1

30

5

Cancer Cell Biology

1

1

30

Steve Sugarman

×

3

Publications

238

Citations

3

H-Index

YearCitations

Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors

Mansoor N. Saleh, Steve Sugarman, James H. Murray,

Journal of Clinical Oncology

2000

194

Pilot Phase II Trial of 13-cis-Retinoic Acid and Interferon-α Combination Therapy for Advanced Pancreatic Adenocarcinoma

Dennis F. Moore, Richard Pazdur, Steve Sugarman,

American Journal of Clinical Oncology

1995

30

Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible

Chau T. Dang, Gabriella D’Andrea, Diana Lake,

Clinical Breast Cancer

2008

14

Page 1